SPERO THERAPEUTICS INC (SPRO)

US84833T1034 - Common Stock

1.43  +0.01 (+0.7%)

After market: 1.4115 -0.02 (-1.29%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
103.78M53.51M18.26M9.33M18.15M
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
76.99M84.08M106.23M88.44M81.36M
Research and Development
51.44M47.59M64.53M67.00M65.78M
Selling, General, and Administrative Expenses
25.55M36.48M41.70M21.44M15.59M
Operating Income
26.79M-30.57M-87.97M-79.11M-63.22M
Interest Income/Expense
3.94M-580.00K-1.39M400.00K1.55M
Other Income/Expense
-14.00K-60.00K-400.00K430.00K740.00K
Non Recurring Items
-5.31M-15.21MN/AN/AN/A
Income Before Taxes
25.40M-46.42M-89.76M-78.28M-60.93M
Income Tax
2.60MN/AN/A0.00N/A
Net Income
22.81M-46.42M-89.76M-78.83M-60.93M
EBITDA
27.15M-29.70M-87.32M-78.35M-62.47M
 
Per Share Data
EPS Diluted Total Ops
0.43-1.23-2.91-3.52-3.35
Non GAAP EPS
0.52-1.66-2.89-3.58-3.30
 
Statistics
Profit Margin
21.98%-86.75%-491.57%-844.91%-335.70%
Operating Profit Margin
25.81%-57.13%-481.76%-847.91%-348.32%

All data in USD

Charts